Clinical Consequences of Delayed Gastric Emptying With GLP-1 Receptor Agonists and Tirzepatide
2024

Effects of GLP-1 Receptor Agonists on Gastric Emptying

Sample size: 35183 publication 10 minutes Evidence: moderate

Author Information

Author(s): Jalleh Ryan, Plummer Mark P, Marathe Chinmay S, Umapathysivam Mahesh M, Quast Daniel R, Rayner Christopher K, Jones Karen L, Wu Tongzhi, Horowitz Michael, Nauck Michael A

Primary Institution: Royal Adelaide Hospital, Adelaide Medical School, The University of Adelaide

Hypothesis

How do GLP-1 receptor agonists affect gastric emptying and gastrointestinal motility?

Conclusion

GLP-1 receptor agonists can slow gastric emptying, which may lead to increased risks of retained gastric contents during medical procedures.

Supporting Evidence

  • GLP-1 receptor agonists are associated with a higher risk of retained gastric contents during endoscopy.
  • Patients on GLP-1RAs had a 4-fold increase in the risk of retained gastric contents compared to non-users.
  • Prolonged fasting and ultrasound examination may help manage risks associated with GLP-1RA therapy.

Takeaway

GLP-1 medications help with diabetes but can slow down how fast your stomach empties, which might cause problems during surgeries.

Methodology

The study involved a literature search of PubMed for studies on GLP-1 receptor agonists and gastrointestinal events.

Potential Biases

Potential reporting bias in retrospective studies.

Limitations

Limited evidence on the periprocedural management of GLP-1RAs and variability in individual responses.

Participant Demographics

Majority of participants had type 2 diabetes.

Statistical Information

P-Value

p<0.0001

Confidence Interval

95% CI 1.04-2.74

Statistical Significance

p<0.0001

Digital Object Identifier (DOI)

10.1210/clinem/dgae719

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication